7-(4-methoxyphenyl)-2-[(2-methylpyrimidin-5-yl)oxymethyl]thieno[3,2-b]pyridine-5-carboxamide

ID: ALA4475753

PubChem CID: 155538001

Max Phase: Preclinical

Molecular Formula: C21H18N4O3S

Molecular Weight: 406.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cc(C(N)=O)nc3cc(COc4cnc(C)nc4)sc23)cc1

Standard InChI:  InChI=1S/C21H18N4O3S/c1-12-23-9-15(10-24-12)28-11-16-7-18-20(29-16)17(8-19(25-18)21(22)26)13-3-5-14(27-2)6-4-13/h3-10H,11H2,1-2H3,(H2,22,26)

Standard InChI Key:  ZPTCDLHDLQDUPO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   32.2705  -11.5754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9802  -11.1660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9774  -10.3433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2687   -9.9381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2722  -12.3904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5628  -12.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5622  -13.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2704  -14.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9805  -13.6115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9776  -12.7964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5625  -11.1665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5637  -10.3499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7875  -10.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3065  -10.7563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7855  -11.4176    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   29.4893  -10.7551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0797  -11.4623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6835   -9.9321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3928  -10.3380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6804   -9.1149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2625  -11.4611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8581  -10.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0417  -10.7527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6312  -11.4603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0432  -12.1710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8583  -12.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2713  -14.8415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8140  -11.4602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5640  -15.2508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4 12  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 14 16  1  0
 16 17  1  0
  3 18  1  0
 18 19  1  0
 18 20  2  0
 17 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  8 27  1  0
 24 28  1  0
 27 29  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4475753

   ---

2. Alternative Forms:

   

   ALA4475753

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 406.47

Molecular Weight (Monoisotopic): 406.1100

AlogP: 3.75

#Rotatable Bonds: 6

Polar Surface Area: 100.22

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.05

CX LogP: 2.90

CX LogD: 2.90

Aromatic Rings: 4

Heavy Atoms: 29

QED Weighted: 0.52

Np Likeness Score: -0.81

References

1. Childress ES, Wieting JM, Felts AS, Breiner MM, Long MF, Luscombe VB, Rodriguez AL, Cho HP, Blobaum AL, Niswender CM, Emmitte KA, Conn PJ, Lindsley CW..  (2018)  Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu₂) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores.,  62  (1): [PMID:30350962] [10.1021/acs.jmedchem.8b01266]

Source

Source(1):

• Scientific Literature